Diacef 2000 мg

Diacef 2000 мg


International unlicensed name: Ceftriaxone

Formulation: 2000 mg powder for preparing solution for injections in vial pack № 1

Reagents: 1 vial contains ceftriaxone sodium, equivalent to 2000 mg ceftriaxone

Auxiliary reagents: none

Pharmacotherapeutic group: Cefalosporin antibiotics

Shelf life: 2 years

Certificate of registry number: UA/123 32/01/01

Certificate validity period: from 05.01.2017 - not limited

The Ministry of Health of Ukraine Order № 7 of 05.01.2017

AO code: J02AC01


Diacef is used for treating infections, whose causative agents are sensitive to ceftriaxone:

  • Respiratory tract infections, especially pneumonia, as well as ear, nose and throat infections;
  • Abdominal cavity infections (peritonitis, biliary and digestive tract infections);
  • Kidney tract and urinary tract infections;
  • Genital infections, including gonorrhea;
  • Sepsis;
  • Bone, joint, soft tissue, skin infections and wound infections;
  • Infections in patients with weakened immune system;
  • Meningitis;
  • Disseminated Lyme borreliosis (early and late stages of the disease);
  • Preoperative prevention of infections in case of surgery on digestive tract, biliary tract, urinary tract organs and gynecological procedures, but only when there is potential or certain contamination.

When prescribing Diacef, it is necessary to follow the official recommendations of antibiotic therapy and the recommendations of antibiotic resistance prophylaxis in particular.